Literature DB >> 28421256

Special issue: recognizing the lifetime scientific contributions of Athina Markou.

John F Cryan1, Harriet de Wit2.   

Abstract

Entities:  

Year:  2017        PMID： 28421256      PMCID： PMC5473252          DOI： 10.1007/s00213-017-4624-7

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  9 in total

Review 1.  Assessing antidepressant activity in rodents: recent developments and future needs.

Authors:  John F Cryan; Athina Markou; Irwin Lucki
Journal:  Trends Pharmacol Sci       Date:  2002-05       Impact factor: 14.819

2.  Stress, anxiety and depression: toward new treatment strategies.

Authors:  Athina Markou; John F Cryan
Journal:  Neuropharmacology       Date:  2011-10-05       Impact factor: 5.250

3.  The GABAB receptor-positive modulator GS39783 and the GABAB receptor agonist baclofen attenuate the reward-facilitating effects of cocaine: intracranial self-stimulation studies in the rat.

Authors:  David A Slattery; Athina Markou; Wolfgang Froestl; John F Cryan
Journal:  Neuropsychopharmacology       Date:  2005-11       Impact factor: 7.853

4.  Dramatic decreases in brain reward function during nicotine withdrawal.

Authors:  M P Epping-Jordan; S S Watkins; G F Koob; A Markou
Journal:  Nature       Date:  1998-05-07       Impact factor: 49.962

5.  Enduring deficits in brain reward function after chronic social defeat in rats: susceptibility, resilience, and antidepressant response.

Authors:  Andre Der-Avakian; Michelle S Mazei-Robison; James P Kesby; Eric J Nestler; Athina Markou
Journal:  Biol Psychiatry       Date:  2014-01-31       Impact factor: 13.382

Review 6.  The ups and downs of addiction: role of metabotropic glutamate receptors.

Authors:  Paul J Kenny; Athina Markou
Journal:  Trends Pharmacol Sci       Date:  2004-05       Impact factor: 14.819

7.  Association between nicotine withdrawal and reward responsiveness in humans and rats.

Authors:  Michele L Pergadia; Andre Der-Avakian; Athina Markou; Diego A Pizzagalli; Manoranjan S D'Souza; Pamela A F Madden; Andrew C Heath; Saul Shiffman
Journal:  JAMA Psychiatry       Date:  2014-11       Impact factor: 21.596

Review 8.  Non-nicotinic neuropharmacological strategies for nicotine dependence: beyond bupropion.

Authors:  John F Cryan; Fabrizio Gasparini; Gino van Heeke; Athina Markou
Journal:  Drug Discov Today       Date:  2003-11-15       Impact factor: 7.851

Review 9.  Anhedonia, avolition, and anticipatory deficits: assessments in animals with relevance to the negative symptoms of schizophrenia.

Authors:  Samuel A Barnes; Andre Der-Avakian; Athina Markou
Journal:  Eur Neuropsychopharmacol       Date:  2013-10-14       Impact factor: 4.600
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.